0001209191-22-036803.txt : 20220614 0001209191-22-036803.hdr.sgml : 20220614 20220614190344 ACCESSION NUMBER: 0001209191-22-036803 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220614 DATE AS OF CHANGE: 20220614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenwood Luba CENTRAL INDEX KEY: 0001853815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39692 FILM NUMBER: 221016207 MAIL ADDRESS: STREET 1: C/O BROOKLYN IMMUNOTHERAPEUTICS LLC STREET 2: 140 58TH STREET, BUILDING A, SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-01 0 0001740279 IN8BIO, INC. INAB 0001853815 Greenwood Luba C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330 NEW YORK NY 10118 1 0 0 0 Stock Option (right to buy) 2.24 2022-06-01 4 A 0 10500 0.00 A 2032-06-01 Common Stock 10500 10500 D One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. /s/ Jason Minio, Attorney-in-Fact 2022-06-14